Dean Woodbine

Dean Woodbine is an experienced professional in patient access and reimbursement, currently serving as Associate Director Patient Access and Reimbursement Liaison at Amgen, formerly Horizon Therapeutics, since October 2023, after a similar role at Horizon beginning in December 2020. Dean's expertise spans various therapeutic areas, including rare diseases and biological therapies, with previous positions at Global Blood Therapeutics, GSK, Regeneron Pharmaceuticals, and Merck & Co. Inc. Notable achievements include successfully guiding healthcare providers through complex reimbursement processes and securing access to specialty therapies, alongside contributions to educational initiatives and relationship building with healthcare stakeholders. Dean holds a Master’s in Business Administration from the University of Miami and a degree in Communication from the University of Central Florida.